Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

Initial surge Of COVID-19 Pandemic Uncovered Rise In Diagnoses Of, Hospitalizations For Anorexia Nervosa In Both Children And Adolescents, Researchers Say

Healio (12/10, Herpen) reported, “The initial surge of the COVID-19 pandemic uncovered a rise in diagnoses of and hospitalizations for anorexia nervosa in both children and adolescents,” researchers concluded in a study that sought to “to determine the frequency and severity of diagnoses in a nationwide cross-section of nearly 1,900 children and adolescents before and during the first wave of the COVID-19 pandemic.” The findings of the Canadian “cross-sectional study” were published online in Dec. 7 in JAMA Network Open.

Related Links:

— “First wave of COVID-19 in Canada magnified incidence of anorexia nervosa “Robert Herpen, Healio, December 10, 2021

Prevalence Of Treatment-Resistant Depression Appears To Vary By Sex, Race, And Age, Data Indicate

Healio (12/10, Gramigna) reported, “Treatment-resistant depression [TRD] prevalence varied by sex, race and age,” investigators concluded in a study that “sought to outline TRD prevalence using two large U.S. claims databases, Humana (n = 296,055 patients) and Optum (n = 277,941).” The study team “analyzed data of patients aged 18 years or older who had pharmaceutically treated depression (PTD)…with at least one major depressive disorder diagnosis based on ICD-10-CM criteria and one antidepressant prescription filled in 2018.” The findings of the “cross-sectional study” were published online Nov. 30 in the Journal of Clinical Psychiatry. “ Females, middle-aged adults, and White patients had higher risk of TRD. The median time from index antidepressant use to TRD was about 6 months in incident PTD patients.”

Related Links:

— “Sex, race, age impact risk for treatment-resistant depression “Joe Gramigna, Healio, December 10, 2021

Physician groups, insurers at odds over coverage for audio-only telehealth visits

Kaiser Health News (12/8, Appleby) reports on the “increasingly heated debate” regarding coverage for audio-only telehealth visits, an issue that “has drawn outsize interest from physician groups.” KHN adds, “Cutting off or reducing audio-only payments could lead providers to sharply curtail telehealth services, warn some physician groups and other experts,” while “other stakeholders, including employers who pay for health coverage, fear payment parity for audio-only telehealth visits could lead to overbilling.” AMA President-elect Jack Resneck Jr., M.D., said, “I take care of patients who drive from two or three hours away and live in places without broadband access. … For these patients, it’s important to have a backup when the video option doesn’t’ work.”

Related Links:

— “Post-Pandemic, What’s a Phone Call From Your Physician Worth? “Julie Appleby, Kaiser Health News, December 8, 2021

Harm Reduction Strategies Will Be Eligible For Federal Grants Under $30M, Three-Year Program Announced By Biden Administration

MedPage Today (12/8, Frieden) reports, “Harm reduction strategies, including syringe service programs and use of fentanyl test strips, will be eligible for federal grants under a $30 million, three-year program announced” on Dec. 8 “by the Biden administration.” What’s more, “in addition to the harm reduction grants – which will be given at a rate of $10 million per year for three years – the administration also released model legislation for states that want to start up or refine their syringe service programs, formerly known as needle exchange programs.” Click here to read more about the grant funding opportunities.

Related Links:

MedPage Today (requires login and subscription)

Local Changes In Opioid Prescription Rates Appear Not To Affect Odds Of Heroin Misuse Or Dependence, Data Suggest

Psychiatric News (12/8) reports, “Local changes in opioid-dispensing rates have a direct effect on individuals’ misuse and dependence on prescription opioids, but they do not affect the odds of heroin misuse or dependence,” investigators concluded after analyzing “2006-2016 data from the National Survey on Drug Use and Health, which surveys about 70,000 individuals aged 12 and older annually, as well as CDC data on county-level opioid dispensing.” The study team then “specifically focused on whether county-level dispensing rates affected respondents’ substance use, frequency of use, and prescription opioid or heroin dependence.” The findings were published online Dec. 8 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.

Related Links:

— “Reduced Opioid Dispensing Found to Stem Opioid Misuse While Not Increasing Heroin Use, Psychiatric News, December 8, 2021

Foundation News

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.